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Summary:
The rate constants and lumped constants (LCs) for [18F]fluorodeoxyglucose ([18F]FDG) and [llC] deoxyglucose ([IIC]DG) were determined in humans for the glucose metabolic rate kinetic model used to mea sure local cerebral glucose consumption. The mean values (± SE) of the LCs for [18F]FDG and [IIC]DG are 0.52 ± 0.028 (n = 9) and 0.56 ± 0.043 (n = 6), respec tively. The mean values (± SE) of the rate constants kj, k' L k�, and k! for [18F]FDG for gray matter are 0.095 ± 0.005, 0.125 ± 0.002, 0.069 ± 0.002, and 0.0055 ± 0.0003, respectively. The corresponding values for white matter are 0.065 ± 0.005, 0.126 ± 0.003,0.066 ± 0.002, The development of the fluorodeoxyglucose (PDG) technique (Reivich et aI., 1977 (Reivich et aI., , 1979 for the quantitative determination of local cerebral glucose metabolism (LCMRgl) has made it possible for the first time to study the regional alterations in glucose consumption in humans in vivo in physiologic and pathophysiologic states (Kuhl et aI., 1980a (Kuhl et aI., , b, 1981 Greenberg et aI., 1981; Phelps et aI., 1981; Reivich and Alavi, 1983) . Both [18p]PDG (Reivich et aI., 1979) and U1C]deoxyglucose ([llC]DG) (Reivich et aI., 1982) have been used as tracers in this tech nique. and 0.0054 ± 0.0006, respectively. Using these values and previously published values for the rate constants for [IIC]DG, the average whole-brain metabolic rates for glu cose in normal subjects measured with [18F]FDG and [IIC]DG are 5.66 ± 0.37 (n = 6) and 4.99 ± 0.23 (n = 6) mgllOO glmin, respectively. These values are not sig nificantly different (t = 1.56, P > 0.10) and agree well with reported values in the literature determined by means of the Kety-Schmidt technique. Key Words: Ce rebral glucose metabolism-[IIC]Deoxyglucose [18F]Fluorodeoxyglucose-Lumped constant-Rate con stants.
Knowledge of the 18p or llC activity distribution in the brain and of the arterial time course of the tracer specific activity enables one to calculate quantitative values for LCMRgl if certain constants required in the operational equation are known.
This report presents the values determined for these constants, i.e., the "lumped constant" (LC) and the kinetic constants for [18p]PDG and [llC]DG in humans, as well as the average brain metabolic rate for glucose in normal awake men. Knowledge of the values of these constants is essential for the quantitative application of this method in the study of various physiologic states and pathologic con ditions. The values of average CMRgl will be com pared with other reported values obtained using the Kety-Schmidt technique (Kety and Schmidt, 1948 (Sokoloff et aI., 1977) . An operational equation has been de-veloped that enables one to determine LCMRgl in terms of measurable parameters. The following as sumptions have been made in the derivation of this On the basis of this model and these assumptions, the following operational equation can be derived (Sokoloff et aI., 1977 
[(A ' V:imx' Km) / (<jJ • V max ' K;;'. )] r (C� / Cp)dtexp[ -(ki + k�)11 iT (C� / Cp) exp[(ki + k!)t]dt operational equation: (a) Glucose and FOG or DG share and compete for a common transport carrier between plasma and brain tissue. (b) Once trans ported into a common homogeneous precursor pool, glucose and FOG or DG either compete for the common carrier for transport back from brain to plasma or for hexokinase for phosphorylation to their respective hexose-6-phosphates. (c) The FDG-6-phosphate (FDG-6-P04) or DG-6-phosphate (DG-6-P04) once formed is not further metabolized and is trapped in the tissues. (d) Since phosphatase ac tivity is negligible in the brain (Hers and DeDuve, 1950; Hers, 1957; Raggi et aI., 1960; Prasannan and Subrahmanyan 1968) , the dephosphorylation of FDG-6-P04 or DG-6-P04 can be ignored. [If the time at which the brain's regional tracer distribution is measured is beyond 1 h from the time of injection, an additional parameter, k:, correcting for the egression of the phosphorylated DG, must be in cluded into the basic kinetic model (Phelps et aI., 1979) .] (e) The local region is homogeneous with respect to blood flow, rates of transport of glucose 1985 (2) where e r( '-) equals the tissue 18F or IIC activity at time ,-. The other terms are as defined above.
Thus, by determining the tissue and arterial plasma concentrations of 18F or IIC activity fol lowing the intravenous administration of a bolus of [18F]FDG or [IIC]DG in humans, it is possible to determine the values of kj, k"2, kj, and k! by a least squares nonlinear fitting procedure.
Determination of LC
It can be demonstrated that following a step change in [18F]FDG or [IIC]DG concentration in the arterial blood, the value of the ratio of the extrac tion ratios for [18F]FDG or [IIC]DG and glucose by the brain multiplied by the ratio of the arterial whole blood to plasma specific activity asymptotically ap proaches the value of the LC (Sokoloff et aI., 1977) if k! if assumed to be zero:
where C� and Ca are the arterial whole-blood con centrations of FDG or DG and glucose, respec tively, and C� and Cy are the cerebral venous whole-blood concentrations of FDG or DG and glu cose, respectively. The other terms are as defined above.
METHODS

Preparation of glucose analogues
[lsFlFDG was prepared as described by Ido et al. (1978) . Subsequent to the use of the [lsFJFDG prepared according to this method in the measurement of the LC reported in the present article, it was reported (Bida et al., 1984; Herscheid et al., 1984 ; Jewett et aI., 1984 ) that a number of electrophilic fluorination methods used to prepare FDG give varying amounts of 2-deoxy-2-fluoro D-mannose (2-FDM), a derivative of DG where the fluo rine occupies the axial position at C-2 rather than the equatorial position as in FDG. On careful examination of the product produced using the fluorination method of Ido et al. (1978) , it was found that the ratio of the FOG to 2-FOM equaled 9: 1 (C. Y. Shiue et aI., unpublished observations). Thin-layer chromatography on silica gel using acetonitrile/H20 (95 :5) and high pressure liquid chromatography using silica gel with acetonitrile/H20 (99: 1) as the eluant or a carbohydrate analysis column (IBM) eluted with acetonitrile/Hp (4: 1) showed that the radiochemical purity was 80-85%. The specific activity (at time of injection) was 2.5-5.0 mCi/mg.
[IIClOG was produced as described by . The radiochemical purity was 97-99% as dc termined by thin-layer chromatography using silica gel plates and acetonitrile/water (90: 10) as the eluant. In ad dition, the trimethylsilyl derivative of the product was formed and subjected to gas-liquid chromatography and radio gas-liquid chromatography (6 ft. x 1/8 in. i.d. column of 4% SE-30 + 6% OV-21O, 150°C, 15 mlimin) and showed only two peaks due to the silylated anomers of DG with retention times of 17 and 24.8 min. The spe cific activity at the time of injection was 128 mCi/mg. Pharmaceutical-quality [18FlFDG and [IIClDG in iso tonic saline were sterilized by terminal Millipore (0.22-fLm) filtration. The preparation were carried out ac cording to a protocol that was demonstrated on three suc cessive runs to yield a sterile pyrogen-free product. [Tests for sterility and apyrogenicity were performed by South Shore Laboratory (Islip, NY, U.S.A.), Leberco Labora tories (Roselle Park, NJ, U.S.A.), and Liuzzi Microbi ology Laboratory (Islip, NY, U.S.A.).l
Determination of kinetic constants
In a series of nine male subjects between the ages of 18 and 25 years, the arterial time course and tissue time course of 18F activity were measured following the intra venous bolus injection of [18FlFDG.
Arterial samples were obtained at the following times after administration of the tracer from a catheter placed percutaneously into a radial artery: every 15 s for 1 min, every 1 min for 9 min, and every 5 min for 50 min; and after 60 min, less frequent samples were taken up to 5 h. The samples were immediately centrifuged, and the plasma was separated and counted in a well counter along with 68Ga standards that had previously been counted in the scanner to enable the blood and tissue activity to be expressed in equivalent units. The tissue time course was obtained by making PET section scans every 3 min for 30 min, at 38 min, and thereafter at less frequent intervals up to 5 h. From these scans, the time course of ISF ac tivity in gray and white matter structures was determined.
Using Eq. 2 and these arterial and tissue time course data, a best fit of values for kj, ki, k�, and k'4 was de termined. To compute an analytical expression for c� (t), the coefficients and exponents of the sum of three ex ponentials were fitted to the plasma activity versus time measurements from the moment of the peak value to the last sample time. The analytical expression for C; (t) from time of injection to the peak plasma activity was esti mated by linear equations between the actual data points. The parameters of the exponential expression were cal culated using the function minimization procedure of Fletcher and Powell (1963) . This explicit expression was then used to represent C� in Eq. 2. Both the data of Phelps et al. (1979) in the human and of Sokoloff et al. (1977) in the rat were used as initial estimates. These estimates led to almost identical convergence results. The integration method of Gear (1971) was used to solve this differential equation, with the Fletcher-Powell minimi zation procedure selecting the best-fit rate constant values. Calculations were performed on a VAX 11/780 computer and convergence obtained in � 30 iterations.
Determination of LC
To determine the LC, a step change in arterial [18FJFOG or [ II CIOG concentration was produced. From knowledge of the time course of arterial [18FlFDG or [ II ClOG activity following their intravenous bolus injec tion, which had been obtained in previous studies (Reivich et al.. 1979 (Reivich et al.. , 1982 Greenberg et al.. 1981) , it was possible to calculate the transfer function of the system. With knowledge of this transfer function, Laplace trans form techniques were used to compute a [18F]FDG or ["C]DG infusion schedule that would produce a step change in arterial tracer concentration (Patlak and Petti grew, 1976) .
The LC for ['8F1FDG was determined in nine normal male subjects aged 21-28 years and the LC for ["C]DG in six normal male subjects aged 20-25 years. A catheter was placed percutaneously into a radial artery and an internal jugular bulb, the latter under fluoroscopic guid ance. Arterial and jugular venous blood samples were obtained during the tracer infusion every 30 s for the first 2.5 min and then every 2.5 min until 40 min for r"C]DG and until 60 min for rIRF]FDG.
The arterial blood samples were divided into fractions for whole-blood counting and whole-blood glucose deter minations. The remainder of the sample was centrifuged for 2 min, and an aliquot of plasma was removed for counting as well as glucose determination. The cerebral venous sample was analyzed only for whole-blood radio activity concentration and glucose concentration. The I S F samples were counted in a Packard Auto gamma-counter, whereas the "C samples were counted in a Picker well counter. In excess of 25,000 counts was obained in each I S F sample and 100,000 counts in each "C sample. An enzymatic, fluorometric method with hexokinase. glu cose-6-phosphate dehydrogenase, and NADP was used for the glucose determinations (Lowry and Passonneau, 1972) .
The arterial plasma samples were also used during the tracer infusion to monitor the step change in tracer con centration being produced. If necessary, slight modifica tions of the infusion schedule were made to ensure that a step change was obtained. Seldom were such modifi cations necessary.
From the arterial and internal jugular venous tracer and glucose concentrations, the ratios of the extraction ratios for these two substances by the brain were calculated according to Eq. 3 and the time course of the ratio plotted. The asymptotic value (A) of this ratio (R) was calculated by fitting the data obtained after 25 min to the expression A + BIR, where B is a constant determined from the data.
Determination of LCMRgI
LCMRgl was measured in two groups of six normal male subjects. The age range of the group tested with [18F]FDG was 19-30 years; that of the group tested with [IIC]DG was 19-28 years. Percutaneous radial artery catheterization was performed using a 20-gauge, 2-in. catheter and the brachial vein was punctured with a 20gauge needle. The arterial line was maintained patent by means of a pressurized drip system and the venous line by means of an intravenous infusion. The subject was then made comfortable in the PET scanner. The ["C]DG studies were performed on the PETT III scanner at Brookhaven National Laboratory. The PETT V scanner at the University of Pennsylvania was used for the [,8F]FDG studies.
The PETT III consists of 48 NaI (TI) scintillation de tectors in a hexagonal array (Ter-Pogossian et aI., 1975) . Each side of the hexagon has eight detectors mounted on a platform capable of rectilinear motion, and the entire 1985 hexagon is mounted on a gantry capable of rotating. With translation of the banks (1 cm) and rotation of the gantry (60° in 3° increments), the radioactivity in the brain tissue is measured from a number of angles. From the measured data, transverse sections through the brain were calcu lated using a filtered, back-projection reconstruction technique (Herman, 1980) . Attenuation correction was performed by approximating the edge of the skull by an ellipse and using an average linear attenuation coefficient (Ter-Pogossian et aI., 1975) . The intrinsic spatial resolu tion of the PETT III in the plane of the section is 17 mm full width at half-maximum. This is a single slice device that requires axial repositioning of the subject to scan other levels.
The PETT V consists of 48 NaI (Tl) scintillation de tectors in a circular array (Ter-Pogossian et aI., 1978) . The motion of scanning is wobbling and rotation, and the re construction is performed using the same filtered, back projection technique as above. This system has intrinsic resolution of 11.5 mm and effective image resolution of 16.5 mm, and generates simultaneously seven cross-sec tional images 17.4 mm thick.
The subjects had their eyes open and ears plugged. Conversation in the room was kept to a minimum and conducted in low tones when absolutely necessary. Ap proximately 30 min after radial artery and brachial vein catheterization, a baseline arterial sample was drawn for ['RF]FDG or r"C]DG, glucose, and blood gases. An in travenous bolus injection of 3.5-11.3 mCi of ["C]DG or 5.4-10.2 mCi of ['8F1FDG was then administered.
Arterial blood samples were obtained as above over a 60-min period. Thirty minutes after the injection of the tracer, scanning was initiated. On the PETT III. one to two scans were obtained in each subject at + 4 cm and + 5 cm above the orbitomeatal plane (OM). Each scan required 10-20 min to obtain and resulted in 0.5 x 106-1.5 x 106 counts in each image. On the PETT V, two scans were obtained of each subject. requiring 16-20 min each, for a total of 14 images with 1.7 x 106-5.9 x 106 counts per image.
Determination of average CMRgI
For comparison with data obtained with the Kety Schmidt technique, average CMRgl for the whole brain was calculated as follows. From each set of scans, the image corresponding to OM + 3.5 to OM + 4.5 cm was selected, i.e., two images for each subject studied with FDG and one image for each subject studied with DG. Each image was displayed in four gray levels, and the area of the brain was defined by an ellipse fit to the 50% intensity level. We routinely reduce the number of gray levels to make the display less dependent on the setting of analogue contrast and background controls. Both inter and intraobserver reproducibility in fitting an ellipse to match the 50% intensity level are extremely high: r = 0.993 and 0.998, respectively. In a series of four subjects studied with PET and nuclear magnetic resonance (NMR), the brain area measured on the NMR scans matched the area determined using the 50% intensity level of the PET scans [ratio of 0.99 ± 0.08 (SD)l.
A large (25 cm diameter) region of interest extending beyond the brain was then placed (0 obtain the total counts (>99%) in the image. Although this approach in cludes the contribution of the scalp to the total counts, this is a small percentage. The effective count density was then calculated by dividing the total counts by the area of the brain. A 6% correction was made for the average ventricular size at OM + 4 cm (Chawluk et aI., 1984a,b) . A 50: 50 gray/white mixture was assumed, and average values for gray and white matter rate constants were used to calculate average metabolic rate.
RESULTS
LC
A typical infusion schedule and resulting arterial [18F]FDG concentration time course are illustrated in Fig. 1 . As can be seen, a fairly good approxi mation to a step change in arterial lI8F]FDG was produced by this technique. Similar data for [llC]DG were obtained. The arterial [18F]FDG con centration varied by less than ± 10% from the mean value from 10 to 60 min in all but one subject. The arterial [1lC]DG concentration did not vary by more than ± 11 % from the mean value from 5 to 40 min in the six subjects, although in the majority of the subjects it did not vary by >6%. Figure 2 is a typical time course of arterial and internal jugular venous concentrations of glucose and [18F]FDG in one of the subjects. Similar data were obtained for [IIC]DG. From these data, the time course of the ratio of the extraction ratios for [18F]FDG or [IIC]DG and glucose was calculated. This is shown for a typical subject in Fig. 3 . The asymptotic value approached by each of these curves was determined as described under Methods and represents the value of the LC. The value for each subject and the mean ± SEM are shown in Ta ble 1. Typical arterial and tissue curves for gray and white matter of 18F activity are shown in Fig. 4 .
The average values ± SEM of kj, k'5., k�, and k� calculated from these data are shown in Ta ble 2. The calculations were made using the models with and without k� included. ' is assumed to be zero. This is illus trated for [18F]FDG where the above-described ratio multi plied by the arterial whole-blood/plasma specific activity ratio is plotted on the ordinate as a function of time following a step change in arterial plasma [18F]FDG activity concentra tion.
Average CMRgl
The average CMRgl calculated as described under Methods is shown in Ta ble 3. The error in the calculation of average CMRgl using various as sumptions in regard to the proportion of white and gray matter is small. This is shown in Ta ble 4. A value of 50% gray matter and 50% white matter was assumed.
DISCUSSION
Kinetic rate constants
Mean gray and white matter values of the kinetic rate constants for FDG in humans are reported since values for individual gray or white matter structures were not significantly different, owing to the large individual variation among subjects.
Te n percent 2-FDM was present in the FDG used in these studies. The effect of this on the measured (1979) . They found that the rate con stants for 2-FDM were approximately twice those for FDG. Thus, the rate constants for FDG reported here may be overestimated by 10%. Since the FDG used in the determination of k* values reported by others probably also contained 2-FDM, compari sons with these values in the literature will be made with our measured values of the rate constants. In addition, the measured values of the rate constants are the appropriate ones to use in calculating the average whole-brain CMRgl in the present studies, since the same tracer was used in determining the k* values and the whole-brain CMRgl. The values obtained for kj, q, k�, and k: can be compared directly with previously reported data for [18F]FDG in humans Friedland et al., 1983; Heiss et al., 1984; Rougemont et al., 1984) . There is remarkably good agreement be- tween the present sets of values for both gray and white matter compared with the data of . There is no significant difference (Stu dent's t test) between the two sets of values for kj, k�, or kj for gray matter or for kj, k�, or k'4 for white matter, whereas k'4 for gray matter is slightly lower (p < 0.02S), i.e., 0.6 compared with 0.7%/ min, kj for white matter is slightly higher (p < 0.02), i.e., 6.6 compared with 4.S%/min. As might be ex pected, using either set of k* values produces no significant difference between the calculated values of LCMRgl [the mean difference is S .8% (t = 0.621,
There is also good agreement with the data of Rougement et al. (1984) . There is no significant dif ference between the two sets of values for kj for gray matter or kj and k� for white matter, whereas k� for gray matter is moderately higher (p < 0.01), i.e., 14.8 compared with 11.S%/min, k"3 for gray matter is moderately higher (p < 0.001), i.e., 7.4 compared with 3.7%/min, and kj for white matter is moderately higher (p < 0.001), i.e., 6.4 compared with 3.2%/min. Excellent agreement is present with the data of Heiss et al. (1984) . There is no significant difference between the two sets of values for k� and kj for gray matter or for kj, k�, and kj for white matter, whereas kj for gray matter is slightly higher (p < O.OS), i.e., 10.S compared with 8.8%/min. However, the data of Friedland et al. (1983) for gray matter are all significantly higher when compared with the other comparable sets of data (Phelps et aI., 1979; present data) . As pointed out by Heiss et al. (1984) , the cortical CMRgI estimated from their data ex ceeds the range of published metabolic rates.
The values of the rate constants for FDG in hu mans can be compared with previously reported values for [llC]DG in humans (Reivich et aI., 1982) . To compare these data directly, the values for the rate constants for FDG calculated using the model containing only kj, k�, and kj were used ( Values are means, with SE in parentheses. Student's t test used to determine significance . " Calculated from data in article. b Significantly different from value in rat (Sokoloff et aI ., 1977) . C Significantly different from value reported by Heiss et al . (1984) . d Significantly different from value reported by Friedland et al . (1983) . e Significantly different from deoxyglucose (Reivich et aI., 1982) . f Significantly different from value reported by Rougemont et al . (1984) . g Significantly different from value reported by Phelps et al. (1979) Human (Friedland et aI., 1983) 0.131 (0.0 10) 0.225 (0.032) 0.106 (0.0 14) 0.0097 (0.00 13) n = 5 analogues of glucose have similar affinities for the facilitated transport system and behave similarly as substrates for hexokinase in the brain.
The value of kj in gray matter for DG in humans is lower (p < 0.001) than that reported in the rat (Sokoloff et aI., 1977) , i.e., 9.0 compared with 18.9%/min, whereas the value of k� in gray matter is higher (p < 0.005), i.e., 10.5 compared with 5.2%/ min. No significant differences were found between rats and humans for white matter. Thus, in general, these analogues of glucose behave similarly in both humans and rats. that pool is equal to In 2/(k� + k�). The half-life of the precursor pool for FDG in humans is slightly greater for white matter than gray matter, but this difference is not statistically significant at the 0.05
Precursor pool turnover
Since the fractional turnover rate of the precursor pool is approximated by (k� + k�) when the effects of k! are neglected, it follows that the half-life of J Cereb Blood Flow Me/abol, Vol, 5, No.2, 1985 Overall mean ± SEM, 5.33 ± 0.23. The calculations in this table are based on data from one of the six tluorodeoxyglucose (FDG) subjects. The mean tissue concentration was calculated as described under Methods. Then. making various assumptions about the relative mass of gray and white matter tissue and the relative tissue concentrations of FDG. metabolic rates were calculated for gray and white matter using the rate constants appropriate for each. The whole-brain value was then calculated using appropriate area weighting. The whole-brain value was calculated using mean gray and white matter rate constants and assuming a 50:50 mix = 5.55.
level. When these data are compared with those of Phelps et al. (1979) , there is no significant difference in the half-life of the precursor pool in either gray or white matter. The gray matter precursor pool turnover half-life of FDG is 3.17 min whereas that of DG is 2.37 min, a difference that is significant at the p < 0.005 level. On the other hand, the differ- ence between the turnover rates of white matter for both glucose analogues is not significant. Similarly, when the turnover of the gray and white matter pre cursor pools for DG in humans is compared with corresponding data in the rat (Sokoloff et aI., 1977) , no significant differences are found. Figure 5 shows the calculated concentrations of FDG-6-P04 expressed as a percentage of total tissue activity as a function of time for gray and white matter. These values are in good agreement with those of Phelps et al. (1979) for FDG in humans and of Reivich et al. (1982) for DG in humans (Fig.  S) as well as those of Sokoloff et al. (1977) for DG in the rat. The rate of FDG-6-P04 formation is slower in the human compared with the rate of DG-6-P04 formation in the rat. This might be ex pected since LCMRgl is significantly lower in hu mans.
Distribution volume
When k'S is negligible, the relationship kj/(k� + kV represents the distribution ratio of DG between tissue and plasma in the steady state. Therefore. it is equivalent to the tissue-plasma partition coeffi cient or, expressed another way, to the distribution volume of DG per unit mass of tissue. The distri bution volume calculated from our data for FDG in gray and white matter in humans is not significantly different from the values reported for FDG in hu mans by Phelps et al. (1979) . It is, however, signif icantly larger than the corresponding values for DG in humans reported by Reivich et al. (1982) . These discrepancies may be related to chemical differ ences between these two analogues of glucose. In deed, Miller and Kinney (1981) , in a study of the comparative rates of uptake, egress, and metabo lism of [l 4 C]DG and [1 4 C]FDG in the rat, found that a number of these parameters are different.
Since glucose is transported into the brain by a saturable facilitated transport mechanism and not by active transport (Buschiazzo et aI., 1970; Cutler and Sipe, 1971; Yudilevich and DeRose. 1971; Betz et aI. , 1973; Fishman, 1973) , the plasma concentra tion of glucose would be expected to be higher than that of the tissue, and thus the distribution volumes would be expected to be < 1.
Assuming an average local cerebral blood volume of 3.1 % due to small vessels in the tissue , the ratio of distribution volumes of FDG in the blood and the tissue can be calculated. Both plasma and brain tissue 18F activities are mea sured directly in our subjects from blood samples and tomographic measurements, respectively. Thirty minutes after the administration of FDG, 0.9% of the measured activity originates from the plasma. Correcting for cerebral hematocrit and the relative distribution of FOG in the red blood cells and plasma, the percentage of activity in the whole blood of the tissue becomes I.S%. Since at 30 min 24.7% of the tissue counts originate from free un metabolized FDG, the value of the distribution J Cereb Blood Flow Metabol. Vol. 5. No.2. 1985 volume of FDG between blood and tissue is O.S1. This agrees fairly well with the value of 0.43 deter mined from the k* values assuming SO% gray and SO% white matter. The corresponding values cal culated from the data of Phelps et al. (1979) . This was obtained by calculating CMRgI for gray and white matter structures in various regions of the brain with the LC set equal to 1.0. These gray and white matter values of glucose consump tion were weighted to yield a whole-brain value for average glucose consumption assuming that the brain is SO% gray and SO% white matter. A normal value of average glucose consumption of S.38 ± 0.77 was assumed from reported values in the lit erature. The ratio of the average brain glucose con sumption as calculated above to this normal value from the literature determined by the Kety-Schmidt technique was assumed to be the value of the LC.
The finite spatial resolution of PET introduces a partial volume effect, thereby causing measurement to represent an admixture of gray and white matter structures. This effect will cause an underestima tion of the activity in gray matter and an overesti mation in white matter. This effect will be greater in gray matter as the structures tend to be smaller. As pointed out by Phelps et al. (1979) , this will cause an underestimation of the LC. Furthermore, the true gray/white proportion (%) in the brain in young adults is �S7:43 (Miller et al., 1980) rather than the SO:SO assumed by Phelps et al. (1979) . This would produce an additional 8% underestimation in the calculated value of the LC. Furthermore, no correction for CSF spaces in the PET scans was made. This would produce an additional underes timation in the calculated value of the LC of �6%. The estimated value would therefore be 0.48, which is in fairly good agreement with our measured value of 0.S2.
When k'S is assumed zero in the DG model and the tracer is infused in such a manner as to produce a constant arterial plasma concentration of tracer, then the LC is the asymptotic value of the ratio of the extraction fraction of DG to that of glucose mul tiplied by the ratio of the specific activities. If k'S is assumed not to be zero, then this is no longer true (Huang et al., 1980) . Instead, the LC is the ratio of the extraction fraction of DG to that of glucose, multiplied by the ratio of the specific activities for only a limited time during the scheduled infusion. The time period during which this relationship holds is dependent on the value of k":,. For a value of k":, between 0.001 and 0.01 min � 1, the LC is approxi mated by this expression to within 3-10%, between 20 and 25 min after a constant plasma tracer con centration has been achieved (see Appendix for method of calculation). In the present study, the data used in estimating the LC were obtained 25-40 min after the start of the infusion, which in all cases was at least 20 min after a constant plasma tracer concentration had been achieved.
The error in LC due to the presence of 10% 2-FDM can be estimated from the data of Robinson et al. (1979) . They performed a kinetic analysis of the brain uptake of 2-FDM and FDG in humans following their intravenous administration. Studies in rats revealed that 2-FDM was taken up by the brain two-thirds as effectively as FDG (G. D. Rob inson, Jr., personal communication). This suggests that any effect on the calculated LC due to the pres ence of 10% 2-FDM would be at most 3%.
The effect of the 15-20% impurity in the FDG used in these studies on the measured LC was eval uated in rats administered tracer containing im purity varying from 10 to 100%. These studies in dicated that the impurity is taken up by the brain 22% as effectively as FDG. The 15-20% impurity could therefore lead to an underestimation of the LC for FDG of 12-16%.
However, the measured value of the LC is the appropriate value to use in calculating the average whole-brain CMRgl in the present studies since the same tracer was used in determining the LC and whole-brain CMRgi. If FDG preparations with dif ferent amounts of impurity are used, then the mea sured value of the LC reported here should be cor rected depending upon the amount and type of im purity.
It should be emphasized here that these mea surements are reported for normal subjects and therefore their use with the [18F]FDG and [llC]DG methods is strictly applicable only to studies of normal subjects. In pathological brain states, the LC may assume several values, thereby necessi tating its measurement and use in the calculation of glycolytic rates. This is supported by the recent work of Crane et al. (1983) who characterized the kinetics of FDG transport and phosphorylation in rat brain and used these data to predict the LC over a wide range of altered cerebral metabolic states. The values for average whole-brain CMRgl were calculated as described under Methods and in cluded a 6% correction for the average ventricular size at OM + 4 cm. This correction was obtained from computed tomography scans performed on normal subjects (Chawluk et aI., 1984a,b) . At the level of OM + 4 cm, �6% of the intracranial cavity consists of ventricular space. This value is in good agreement with estimates from the literature, which range from 4.6 to 7.9% (Synek and Reuben, 1976; Gado et aI., 1982; Damasio et aI., 1983; George et al., 1983) .
The values for average whole-brain CMRgl de termined with [llC]DG and [18F]FDG and the ap propriate values of the rate constants and LC re ported here in normal young male subjects were 4.99 ± 0.23 and 5.66 ± 0.37 mg/100 g/min, respec tively. These values are not significantly different (t = 1.56, df = 10, P > 0.10), and they both agree well with reported values in the literature obtained using the Kety-Schmidt technique. The average value from four series in the literature is 5.35 ± 0.33 mg/iOO g/min ( 
where F is the blood flow rate per unit mass of the tissue element; C; and C� are the concentrations of 18F in the arterial blood and cerebral venous blood leaving the tissue element, respectively; Cf is the concentration of 18F in the tissue element; C� is the free (unmetabolized) [18F1FDG in the tissue element; and v* is the rate of change of [18F1FDG-6-P04. Since the glucose utilization rate in the tis sue is in a steady state, the Fick equation for glu cose is (A2)
where C A and C v are the concentrations of glucose in the arterial and cerebral venous blood leaving the tissue element, respectively, and Rj is the net glu cose utilization rate in the tissue element.
Dividing Eqs. Al and A2 gives
where <l> is the fraction of glucose that, once phos phorylated, is metabolized further and v is the rate of phosphorylation of glucose. Consider the first term on the right-hand side of Eq. A3. As derived by Phelps et al. (1979) , C� can be expressed in terms of the arterial plasma l8F concentration (C�) and the kinetic constants (kj, k'2, forward and re verse first-order transport constants of FDG at the capillary membrane, respectively; kj, k;" rate of phosphorylation and dephosphorylation of [18F1FDG, respectively):
kj ---[(k! -(X,)e-cqt + «(X2 -"�)e-" 2 tl ® c�(t) (X2 -(X, where <Xl = k 2!4 -Y (k2!4) 2 -4k'2k412 <X2 = k 2!4 + Y (k2!4) 2 -4"-1k4/2 k 2!4 = k'2 + k! + k4 and ® denotes convolution.
Let C �(t) be a step function; the procedure for obtaining this experimentally is discussed in the text.
J Cereh Blood Flow Metabol, Vol. 5, No.2, 1985 By differentiating Eq. A4, an expression for dC�/ dt is obtained:
Examine now the second term of the right side of Eq. A3. As discussed by Sokoloff et ai. (1977) and Reivich et ai. (1979) 
This ratio is shown in Fig. 6 for three values of k'4:
the value obtained in the present study and values 50 and 200% of the measured value. For compar ison, this ratio is also shown with a k'4 value of zero.
As can be seen, with the measured value of k� (0.0055), the expression [(C� -C�)I(CA -C v)] / (C�/C p) overestimates the value of the LC by 7-10% in the time period 25-50 min after the start of the radionuclide infusion. 
